Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors (dual agonist)
Novo Nordisk's NovoCare program and Eli Lilly's direct-to-consumer options let you get semaglutide or tirzepatide directly from the pharmaceutical companies at set prices, usually $400 to $500 per month, without insurance involvement
Benefits of Semaglutide For Patients With Obesity And Alcohol Use Disorder Patients with both obesity and alcohol use disorder face unique challenges that require comprehensive care
Therefore, successfully launching new muscle-preserving therapies will require extensive market shaping activities to create awareness of unmet need around the risk and implications of muscle loss, to build advocacy for the need to treat, the role of novel pharmacotherapeutic approaches and their clinical, economic and patient-relevant benefits
Tirzepatide was associated with a significantly lower incidence of cataract development compared to Naltrexone/Bupropion (HR 0.46
However, clinicians today rely on a growing body of GLP-1 thyroid cancer human data to guide counseling and risk assessment
